Unless you are adamant that you are going to go to 7 years, all this is doing is creating uncertainty within the pharmaceutical industry and making them not want to invest.
Editor's note · Context
Schock highlights the uncertainty caused by potential changes to biologics protection, urging clarity.
Share & report
More from Aaron Schock
I would submit to you that there is no value that can be placed on good government or having the will of the people in terms of who they wish to represent them here in the United States Senate.
If I, as a Member, am going to have to vote on one of the largest spending increases in our country's history, then I believe we ought to be able to weigh in on where that money is spent.
The IFA supports enactment of this tax credit for the franchise systems that choose to offer qualified veterans a discounted franchise fee.
The changes this Committee is making here today will go a long way to ensuring that the SBIR program is continued to be used as a resource which helps small businesses bring their new and novel ideas to commercialization while also…





